On February 14, 2023, Oblato, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,450 KRW | +4.78% | -17.68% | +69.90% |
1st Jan change | Capi. | |
---|---|---|
+69.90% | 412M | |
-4.44% | 23.38B | |
+4.89% | 8.58B | |
+7.83% | 8.46B | |
-21.35% | 7.94B | |
+13.31% | 5.3B | |
+10.84% | 4.14B | |
-1.97% | 4.12B | |
-2.34% | 3.87B | |
+20.72% | 3.68B |
- Stock Market
- Equities
- A115450 Stock
- News HLB Therapeutics Co.,Ltd.
- Oblato, Inc. announced that it has received KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.